MK
Matthew W. Kalnik
SVP Strategic Plan. & Bus. Ops

Matthew W. Kalnik insider trades: Nabi Biopharmaceuticals (NABI) stock sales

SVP Strategic Plan. & Bus. Ops, Nabi Biopharmaceuticals Last trade Apr 1, 2011 10 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2009
1
Company
last trade 2011

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Matthew reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Apr 1, 2011NABI↓ Sell$37K
Jul 26, 2010NABI↓ Sell$9K
Jul 19, 2010NABI↓ Sell$9K
Apr 13, 2010NABI↓ Sell$13K
Apr 1, 2010NABI↓ Sell$11K
Mar 17, 2010NABI↓ Sell$59K
Mar 11, 2010NABI↓ Sell$7K
Mar 2, 2010NABI↓ Sell$12K
Nov 17, 2009NABI↓ Sell$34K
Nov 16, 2009NABI↓ Sell$34K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Matthew W. Kalnik's insider trades

Matthew W. Kalnik is SVP Strategic Plan. & Bus. Ops at Nabi Biopharmaceuticals (NABI). Since Nov 16, 2009, Matthew has reported no open-market purchases and 10 sales worth $224K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (3 filings), option exercises (2 filings), inherited shares (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NABI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.